从2000年到2019年,拉丁美洲和加勒比国家与腹有关的死亡率
Raquel Gutierrez Adrianzen1, Carlos Quispe-Vicuña1, Wagner Rios-Garcia1
1Latin American Network for Cancer Research (LAN-CANCER), Lima, Peru.
Journal of epidemiology and global health
|October 20, 2025
概括
从2000年到2019年,拉丁美洲和加勒比国家的腹死亡率显著下降,特别是在儿童中. 公共卫生工作推动了儿童死亡率的这些积极趋势.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 全球健康 全球健康
背景情况:
- 腹是拉丁美洲和加勒比地区 (LAC) 可预防死亡的主要原因,特别影响儿童.
- 关于发展中国家腹死亡率的最新趋势的数据有限.
- 本研究研究了从2000年到2019年在LAC国家腹死亡率的演变.
研究的目的:
- 确定拉丁美洲和加勒比国家腹死亡率的趋势和变化.
- 分析2000年至2019年期间腹死亡率的演变.
- 为了确定腹死亡率的特定国家和人口变化.
主要方法:
- 使用世卫组织死亡数据 (2000-2019年) 的生态观测时间序列研究.
- 加入点回归软件用于分析死亡率趋势和按性别和国家每年的百分比变化.
- 对2015-2019年期间年龄标准化死亡率 (ASMR) 的分析.
主要成果:
- 大多数LAC国家在2000年至2019年期间,所有年龄组和性别的腹死亡率显著下降.
- 厄瓜多尔,哥斯达黎加和萨尔瓦多的腹死亡率下降幅度最大.
- 在2015-2019年,危地马拉和圭亚那的ASMR最高,而智利和阿根廷的ASMR最低.
结论:
- 在LAC国家,与腹相关的死亡率在20年 (2000-2019) 期间显著下降.
- 公共卫生干预和政策被认为是推动这些减少的原因.
- 持续监测和有针对性的干预措施对于进一步降低腹导致的儿童死亡率至关重要.
相关概念视频
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
419
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
419
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
564
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
564
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
611
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
611
Drugs for Treatment of Diarrhea-Predominant IBS
625
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
625
Factors Influencing Drug Absorption: Disease States and Pharmacology
1.3K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.3K
Fungal Phylum Microsporidia
417
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
417


